Priority Intervention Targets Identified Using an In-Depth Sampling HIV Molecular Network in a Non-Subtype B Epidemics Area

Molecular network analysis based on the genetic similarity of HIV-1 is increasingly used to guide targeted interventions. Nevertheless, there is a lack of experience regarding molecular network inferences and targeted interventions in combination with epidemiological information in areas with divers...

Full description

Bibliographic Details
Main Authors: Bin Zhao, Wei Song, Minghui An, Xue Dong, Xin Li, Lu Wang, Jianmin Liu, Wen Tian, Zhen Wang, Haibo Ding, Xiaoxu Han, Hong Shang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2021.642903/full
id doaj-e89fb0a36ea7494eafbab44a9d4f3e45
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Bin Zhao
Bin Zhao
Bin Zhao
Bin Zhao
Wei Song
Minghui An
Minghui An
Minghui An
Minghui An
Xue Dong
Xin Li
Lu Wang
Jianmin Liu
Wen Tian
Wen Tian
Wen Tian
Wen Tian
Zhen Wang
Zhen Wang
Zhen Wang
Zhen Wang
Haibo Ding
Haibo Ding
Haibo Ding
Haibo Ding
Xiaoxu Han
Xiaoxu Han
Xiaoxu Han
Xiaoxu Han
Hong Shang
Hong Shang
Hong Shang
Hong Shang
spellingShingle Bin Zhao
Bin Zhao
Bin Zhao
Bin Zhao
Wei Song
Minghui An
Minghui An
Minghui An
Minghui An
Xue Dong
Xin Li
Lu Wang
Jianmin Liu
Wen Tian
Wen Tian
Wen Tian
Wen Tian
Zhen Wang
Zhen Wang
Zhen Wang
Zhen Wang
Haibo Ding
Haibo Ding
Haibo Ding
Haibo Ding
Xiaoxu Han
Xiaoxu Han
Xiaoxu Han
Xiaoxu Han
Hong Shang
Hong Shang
Hong Shang
Hong Shang
Priority Intervention Targets Identified Using an In-Depth Sampling HIV Molecular Network in a Non-Subtype B Epidemics Area
Frontiers in Cellular and Infection Microbiology
HIV-1
molecular networks
genetic distance threshold
molecular clusters
sociodemographic characters
author_facet Bin Zhao
Bin Zhao
Bin Zhao
Bin Zhao
Wei Song
Minghui An
Minghui An
Minghui An
Minghui An
Xue Dong
Xin Li
Lu Wang
Jianmin Liu
Wen Tian
Wen Tian
Wen Tian
Wen Tian
Zhen Wang
Zhen Wang
Zhen Wang
Zhen Wang
Haibo Ding
Haibo Ding
Haibo Ding
Haibo Ding
Xiaoxu Han
Xiaoxu Han
Xiaoxu Han
Xiaoxu Han
Hong Shang
Hong Shang
Hong Shang
Hong Shang
author_sort Bin Zhao
title Priority Intervention Targets Identified Using an In-Depth Sampling HIV Molecular Network in a Non-Subtype B Epidemics Area
title_short Priority Intervention Targets Identified Using an In-Depth Sampling HIV Molecular Network in a Non-Subtype B Epidemics Area
title_full Priority Intervention Targets Identified Using an In-Depth Sampling HIV Molecular Network in a Non-Subtype B Epidemics Area
title_fullStr Priority Intervention Targets Identified Using an In-Depth Sampling HIV Molecular Network in a Non-Subtype B Epidemics Area
title_full_unstemmed Priority Intervention Targets Identified Using an In-Depth Sampling HIV Molecular Network in a Non-Subtype B Epidemics Area
title_sort priority intervention targets identified using an in-depth sampling hiv molecular network in a non-subtype b epidemics area
publisher Frontiers Media S.A.
series Frontiers in Cellular and Infection Microbiology
issn 2235-2988
publishDate 2021-03-01
description Molecular network analysis based on the genetic similarity of HIV-1 is increasingly used to guide targeted interventions. Nevertheless, there is a lack of experience regarding molecular network inferences and targeted interventions in combination with epidemiological information in areas with diverse epidemic strains of HIV-1.We collected 2,173 pol sequences covering 84% of the total newly diagnosed HIV-1 infections in Shenyang city, Northeast China, between 2016 and 2018. Molecular networks were constructed using the optimized genetic distance threshold for main subtypes obtained using sensitivity analysis of plausible threshold ranges. The transmission rates (TR) of each large cluster were assessed using Bayesian analyses. Molecular clusters with the characteristics of ≥5 newly diagnosed cases in 2018, high TR, injection drug users (IDUs), and transmitted drug resistance (TDR) were defined as priority clusters. Several HIV-1 subtypes were identified, with a predominance of CRF01_AE (71.0%, 1,542/2,173), followed by CRF07_BC (18.1%, 393/2,173), subtype B (4.5%, 97/2,173), other subtypes (2.6%, 56/2,173), and unique recombinant forms (3.9%, 85/2,173). The overall optimal genetic distance thresholds for CRF01_AE and CRF07_BC were both 0.007 subs/site. For subtype B, it was 0.013 subs/site. 861 (42.4%) sequences of the top three subtypes formed 239 clusters (size: 2-77 sequences), including eight large clusters (size ≥10 sequences). All the eight large clusters had higher TR (median TR = 52.4/100 person-years) than that of the general HIV infections in Shenyang (10.9/100 person-years). A total of ten clusters including 231 individuals were determined as priority clusters for targeted intervention, including eight large clusters (five clusters with≥5 newly diagnosed cases in 2018, one cluster with IDUs, and two clusters with TDR (K103N, Q58E/V179D), one cluster with≥5 newly diagnosed cases in 2018, and one IDUs cluster. In conclusion, a comprehensive analysis combining in-depth sampling HIV-1 molecular networks construction using subtype-specific optimal genetic distance thresholds, and baseline epidemiological information can help to identify the targets of priority intervention in an area epidemic for non-subtype B.
topic HIV-1
molecular networks
genetic distance threshold
molecular clusters
sociodemographic characters
url https://www.frontiersin.org/articles/10.3389/fcimb.2021.642903/full
work_keys_str_mv AT binzhao priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT binzhao priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT binzhao priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT binzhao priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT weisong priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT minghuian priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT minghuian priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT minghuian priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT minghuian priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT xuedong priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT xinli priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT luwang priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT jianminliu priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT wentian priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT wentian priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT wentian priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT wentian priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT zhenwang priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT zhenwang priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT zhenwang priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT zhenwang priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT haiboding priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT haiboding priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT haiboding priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT haiboding priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT xiaoxuhan priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT xiaoxuhan priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT xiaoxuhan priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT xiaoxuhan priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT hongshang priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT hongshang priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT hongshang priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
AT hongshang priorityinterventiontargetsidentifiedusinganindepthsamplinghivmolecularnetworkinanonsubtypebepidemicsarea
_version_ 1724199126773530624
spelling doaj-e89fb0a36ea7494eafbab44a9d4f3e452021-03-29T05:41:48ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882021-03-011110.3389/fcimb.2021.642903642903Priority Intervention Targets Identified Using an In-Depth Sampling HIV Molecular Network in a Non-Subtype B Epidemics AreaBin Zhao0Bin Zhao1Bin Zhao2Bin Zhao3Wei Song4Minghui An5Minghui An6Minghui An7Minghui An8Xue Dong9Xin Li10Lu Wang11Jianmin Liu12Wen Tian13Wen Tian14Wen Tian15Wen Tian16Zhen Wang17Zhen Wang18Zhen Wang19Zhen Wang20Haibo Ding21Haibo Ding22Haibo Ding23Haibo Ding24Xiaoxu Han25Xiaoxu Han26Xiaoxu Han27Xiaoxu Han28Hong Shang29Hong Shang30Hong Shang31Hong Shang32NHC Key Laboratory of AIDS Immunology (China Medical University), National Clinical Research Center for Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang, ChinaLaboratory Medicine Innovation Unit, Chinese Academy of Medical Sciences, Shenyang, ChinaKey Laboratory of AIDS Immunology of Liaoning Province, Shenyang, ChinaCollaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, ChinaDepartment of Food Safety and Nutrition, Shenyang Center for Health Service and Administrative Law Enforcement (Shenyang Center for Disease Control and Prevention), Shenyang, ChinaNHC Key Laboratory of AIDS Immunology (China Medical University), National Clinical Research Center for Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang, ChinaLaboratory Medicine Innovation Unit, Chinese Academy of Medical Sciences, Shenyang, ChinaKey Laboratory of AIDS Immunology of Liaoning Province, Shenyang, ChinaCollaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, ChinaDepartment of Food Safety and Nutrition, Shenyang Center for Health Service and Administrative Law Enforcement (Shenyang Center for Disease Control and Prevention), Shenyang, ChinaDepartment of Food Safety and Nutrition, Shenyang Center for Health Service and Administrative Law Enforcement (Shenyang Center for Disease Control and Prevention), Shenyang, ChinaDepartment of Food Safety and Nutrition, Shenyang Center for Health Service and Administrative Law Enforcement (Shenyang Center for Disease Control and Prevention), Shenyang, ChinaDepartment of Food Safety and Nutrition, Shenyang Center for Health Service and Administrative Law Enforcement (Shenyang Center for Disease Control and Prevention), Shenyang, ChinaNHC Key Laboratory of AIDS Immunology (China Medical University), National Clinical Research Center for Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang, ChinaLaboratory Medicine Innovation Unit, Chinese Academy of Medical Sciences, Shenyang, ChinaKey Laboratory of AIDS Immunology of Liaoning Province, Shenyang, ChinaCollaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, ChinaNHC Key Laboratory of AIDS Immunology (China Medical University), National Clinical Research Center for Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang, ChinaLaboratory Medicine Innovation Unit, Chinese Academy of Medical Sciences, Shenyang, ChinaKey Laboratory of AIDS Immunology of Liaoning Province, Shenyang, ChinaCollaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, ChinaNHC Key Laboratory of AIDS Immunology (China Medical University), National Clinical Research Center for Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang, ChinaLaboratory Medicine Innovation Unit, Chinese Academy of Medical Sciences, Shenyang, ChinaKey Laboratory of AIDS Immunology of Liaoning Province, Shenyang, ChinaCollaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, ChinaNHC Key Laboratory of AIDS Immunology (China Medical University), National Clinical Research Center for Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang, ChinaLaboratory Medicine Innovation Unit, Chinese Academy of Medical Sciences, Shenyang, ChinaKey Laboratory of AIDS Immunology of Liaoning Province, Shenyang, ChinaCollaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, ChinaNHC Key Laboratory of AIDS Immunology (China Medical University), National Clinical Research Center for Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang, ChinaLaboratory Medicine Innovation Unit, Chinese Academy of Medical Sciences, Shenyang, ChinaKey Laboratory of AIDS Immunology of Liaoning Province, Shenyang, ChinaCollaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, ChinaMolecular network analysis based on the genetic similarity of HIV-1 is increasingly used to guide targeted interventions. Nevertheless, there is a lack of experience regarding molecular network inferences and targeted interventions in combination with epidemiological information in areas with diverse epidemic strains of HIV-1.We collected 2,173 pol sequences covering 84% of the total newly diagnosed HIV-1 infections in Shenyang city, Northeast China, between 2016 and 2018. Molecular networks were constructed using the optimized genetic distance threshold for main subtypes obtained using sensitivity analysis of plausible threshold ranges. The transmission rates (TR) of each large cluster were assessed using Bayesian analyses. Molecular clusters with the characteristics of ≥5 newly diagnosed cases in 2018, high TR, injection drug users (IDUs), and transmitted drug resistance (TDR) were defined as priority clusters. Several HIV-1 subtypes were identified, with a predominance of CRF01_AE (71.0%, 1,542/2,173), followed by CRF07_BC (18.1%, 393/2,173), subtype B (4.5%, 97/2,173), other subtypes (2.6%, 56/2,173), and unique recombinant forms (3.9%, 85/2,173). The overall optimal genetic distance thresholds for CRF01_AE and CRF07_BC were both 0.007 subs/site. For subtype B, it was 0.013 subs/site. 861 (42.4%) sequences of the top three subtypes formed 239 clusters (size: 2-77 sequences), including eight large clusters (size ≥10 sequences). All the eight large clusters had higher TR (median TR = 52.4/100 person-years) than that of the general HIV infections in Shenyang (10.9/100 person-years). A total of ten clusters including 231 individuals were determined as priority clusters for targeted intervention, including eight large clusters (five clusters with≥5 newly diagnosed cases in 2018, one cluster with IDUs, and two clusters with TDR (K103N, Q58E/V179D), one cluster with≥5 newly diagnosed cases in 2018, and one IDUs cluster. In conclusion, a comprehensive analysis combining in-depth sampling HIV-1 molecular networks construction using subtype-specific optimal genetic distance thresholds, and baseline epidemiological information can help to identify the targets of priority intervention in an area epidemic for non-subtype B.https://www.frontiersin.org/articles/10.3389/fcimb.2021.642903/fullHIV-1molecular networksgenetic distance thresholdmolecular clusterssociodemographic characters